Report cover image

Alendronate

Publisher Cognitive Market Research
Published Mar 01, 2026
SKU # COG21170500

Description

According to Cognitive Market Research, the global Alendronate market size was USD 102151.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 6.50% from 2024 to 2031.

North America held the major market share for more than 40% of the global revenue with a market size of USD 40860.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2031.

Europe accounted for a market share of over 30% of the global revenue with a market size of USD 30645.36 million.

Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 23494.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.

Latin America had a market share of more than 5% of the global revenue with a market size of USD 5107.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.

Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 2043.02 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

The Postmenopausal Osteoporosis segment category is the fastest growing segment of the Alendronate industry

Table of Contents

Chapter 1 2026 Geopolitical Outlook - Alendronate Market Detailed Analysis
Chapter 2 AI's Impact on Market - Detailed Qualitative Analysis
Chapter 3 Global Market Analysis
3.1 Global Alendronate Revenue Market Size, Trend Analysis 2022 - 2034
3.2 Global Alendronate Market Size By Regions 2022 - 2034
3.2.1 Global Alendronate Revenue Market Size By Region
3.3 Global Alendronate Market Size By Product Type 2022 - 2034
3.3.1 Tablets Market Size
3.3.2 Oral Solutions Market Size
3.3.3 Injectable Forms Market Size
3.4 Global Alendronate Market Size By Dosage Strength 2022 - 2034
3.4.1 5 mg Market Size
3.4.2 10 mg Market Size
3.4.3 35 mg Market Size
3.4.4 70 mg Market Size
3.5 Global Alendronate Market Size By Application 2022 - 2034
3.5.1 Postmenopausal Osteoporosis Market Size
3.5.2 Osteoporosis in Men Market Size
3.5.3 Paget’s Disease of Bone Market Size
3.5.4 Others Market Size
3.6 Global Alendronate Market Size By Route of Administration for 2022 - 2034
3.6.1 Oral Market Size
3.6.2 Injectable Market Size
3.7 Global Alendronate Market Size By Distribution Channel for 2022 - 2034
3.7.1 Hospital Pharmacies Market Size
3.7.2 Retail Pharmacies Market Size
3.7.3 Online Pharmacies Market Size
3.8 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
3.9 Executive Summary Global Market (2021 vs 2025 vs 2033)
3.9.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
3.9.2 Global Market Revenue Split By Product Type
3.9.3 Global Market Revenue Split By Dosage Strength
3.9.4 Global Market Revenue Split By Application
3.9.5 Global Market Revenue Split By Route of Administration
3.9.6 Global Market Revenue Split By Distribution Channel
3.9.7 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Chapter 4 North America Market Analysis
4.1 North America Alendronate Market Outlook
4.1.1 North America Alendronate Market Size 2022 - 2034
4.1.2 North America Alendronate Market Size By Country 2022 - 2034
4.1.3 North America Alendronate Market Size by Product Type 2022 - 2034
4.1.3.1 North America Tablets Market Size
4.1.3.2 North America Oral Solutions Market Size
4.1.3.3 North America Injectable Forms Market Size
4.1.4 North America Alendronate Market Size by Dosage Strength 2022 - 2034
4.1.4.1 North America 5 mg Market Size
4.1.4.2 North America 10 mg Market Size
4.1.4.3 North America 35 mg Market Size
4.1.4.4 North America 70 mg Market Size
4.1.5 North America Alendronate Market Size by Application 2022 - 2034
4.1.5.1 North America Postmenopausal Osteoporosis Market Size
4.1.5.2 North America Osteoporosis in Men Market Size
4.1.5.3 North America Paget’s Disease of Bone Market Size
4.1.5.4 North America Others Market Size
4.1.6 North America Alendronate Market Size by Route of Administration 2022 - 2034
4.1.6.1 North America Oral Market Size
4.1.6.2 North America Injectable Market Size
4.1.7 North America Alendronate Market Size by Distribution Channel 2022 - 2034
4.1.7.1 North America Hospital Pharmacies Market Size
4.1.7.2 North America Retail Pharmacies Market Size
4.1.7.3 North America Online Pharmacies Market Size
Chapter 5 Europe Market Analysis
5.1 Europe Alendronate Market Outlook
5.1.1 Europe Alendronate Market Size 2022 - 2034
5.1.2 Europe Alendronate Market Size By Country 2022 - 2034
5.1.3 Europe Alendronate Market Size by Product Type 2022 - 2034
5.1.3.1 Europe Tablets Market Size
5.1.3.2 Europe Oral Solutions Market Size
5.1.3.3 Europe Injectable Forms Market Size
5.1.4 Europe Alendronate Market Size by Dosage Strength 2022 - 2034
5.1.4.1 Europe 5 mg Market Size
5.1.4.2 Europe 10 mg Market Size
5.1.4.3 Europe 35 mg Market Size
5.1.4.4 Europe 70 mg Market Size
5.1.5 Europe Alendronate Market Size by Application 2022 - 2034
5.1.5.1 Europe Postmenopausal Osteoporosis Market Size
5.1.5.2 Europe Osteoporosis in Men Market Size
5.1.5.3 Europe Paget’s Disease of Bone Market Size
5.1.5.4 Europe Others Market Size
5.1.6 Europe Alendronate Market Size by Route of Administration 2022 - 2034
5.1.6.1 Europe Oral Market Size
5.1.6.2 Europe Injectable Market Size
5.1.7 Europe Alendronate Market Size by Distribution Channel 2022 - 2034
5.1.7.1 Europe Hospital Pharmacies Market Size
5.1.7.2 Europe Retail Pharmacies Market Size
5.1.7.3 Europe Online Pharmacies Market Size
Chapter 6 Asia Pacific Market Analysis
6.1 Asia Pacific Alendronate Market Outlook
6.1.1 Asia Pacific Alendronate Market Size 2022 - 2034
6.1.2 Asia Pacific Alendronate Market Size By Country 2022 - 2034
6.1.3 Asia Pacific Alendronate Market Size by Product Type 2022 - 2034
6.1.3.1 Asia Pacific Tablets Market Size
6.1.3.2 Asia Pacific Oral Solutions Market Size
6.1.3.3 Asia Pacific Injectable Forms Market Size
6.1.4 Asia Pacific Alendronate Market Size by Dosage Strength 2022 - 2034
6.1.4.1 Asia Pacific 5 mg Market Size
6.1.4.2 Asia Pacific 10 mg Market Size
6.1.4.3 Asia Pacific 35 mg Market Size
6.1.4.4 Asia Pacific 70 mg Market Size
6.1.5 Asia Pacific Alendronate Market Size by Application 2022 - 2034
6.1.5.1 Asia Pacific Postmenopausal Osteoporosis Market Size
6.1.5.2 Asia Pacific Osteoporosis in Men Market Size
6.1.5.3 Asia Pacific Paget’s Disease of Bone Market Size
6.1.5.4 Asia Pacific Others Market Size
6.1.6 Asia Pacific Alendronate Market Size by Route of Administration 2022 - 2034
6.1.6.1 Asia Pacific Oral Market Size
6.1.6.2 Asia Pacific Injectable Market Size
6.1.7 Asia Pacific Alendronate Market Size by Distribution Channel 2022 - 2034
6.1.7.1 Asia Pacific Hospital Pharmacies Market Size
6.1.7.2 Asia Pacific Retail Pharmacies Market Size
6.1.7.3 Asia Pacific Online Pharmacies Market Size
Chapter 7 South America Market Analysis
7.1 South America Alendronate Market Outlook
7.1.1 South America Alendronate Market Size 2022 - 2034
7.1.2 South America Alendronate Market Size By Country 2022 - 2034
7.1.3 South America Alendronate Market Size by Product Type 2022 - 2034
7.1.3.1 South America Tablets Market Size
7.1.3.2 South America Oral Solutions Market Size
7.1.3.3 South America Injectable Forms Market Size
7.1.4 South America Alendronate Market Size by Dosage Strength 2022 - 2034
7.1.4.1 South America 5 mg Market Size
7.1.4.2 South America 10 mg Market Size
7.1.4.3 South America 35 mg Market Size
7.1.4.4 South America 70 mg Market Size
7.1.5 South America Alendronate Market Size by Application 2022 - 2034
7.1.5.1 South America Postmenopausal Osteoporosis Market Size
7.1.5.2 South America Osteoporosis in Men Market Size
7.1.5.3 South America Paget’s Disease of Bone Market Size
7.1.5.4 South America Others Market Size
7.1.6 South America Alendronate Market Size by Route of Administration 2022 - 2034
7.1.6.1 South America Oral Market Size
7.1.6.2 South America Injectable Market Size
7.1.7 South America Alendronate Market Size by Distribution Channel 2022 - 2034
7.1.7.1 South America Hospital Pharmacies Market Size
7.1.7.2 South America Retail Pharmacies Market Size
7.1.7.3 South America Online Pharmacies Market Size
Chapter 8 Middle East Market Analysis
8.1 Middle East Alendronate Market Outlook
8.1.1 Middle East Alendronate Market Size 2022 - 2034
8.1.2 Middle East Alendronate Market Size By Country 2022 - 2034
8.1.3 Middle East Alendronate Market Size by Product Type 2022 - 2034
8.1.3.1 Middle East Tablets Market Size
8.1.3.2 Middle East Oral Solutions Market Size
8.1.3.3 Middle East Injectable Forms Market Size
8.1.4 Middle East Alendronate Market Size by Dosage Strength 2022 - 2034
8.1.4.1 Middle East 5 mg Market Size
8.1.4.2 Middle East 10 mg Market Size
8.1.4.3 Middle East 35 mg Market Size
8.1.4.4 Middle East 70 mg Market Size
8.1.5 Middle East Alendronate Market Size by Application 2022 - 2034
8.1.5.1 Middle East Postmenopausal Osteoporosis Market Size
8.1.5.2 Middle East Osteoporosis in Men Market Size
8.1.5.3 Middle East Paget’s Disease of Bone Market Size
8.1.5.4 Middle East Others Market Size
8.1.6 Middle East Alendronate Market Size by Route of Administration 2022 - 2034
8.1.6.1 Middle East Oral Market Size
8.1.6.2 Middle East Injectable Market Size
8.1.7 Middle East Alendronate Market Size by Distribution Channel 2022 - 2034
8.1.7.1 Middle East Hospital Pharmacies Market Size
8.1.7.2 Middle East Retail Pharmacies Market Size
8.1.7.3 Middle East Online Pharmacies Market Size
Chapter 9 Africa Market Analysis
9.1 Africa Alendronate Market Outlook
9.1.1 Africa Alendronate Market Size 2022 - 2034
9.1.2 Africa Alendronate Market Size By Country 2022 - 2034
9.1.3 Africa Alendronate Market Size by Product Type 2022 - 2034
9.1.3.1 Africa Tablets Market Size
9.1.3.2 Africa Oral Solutions Market Size
9.1.3.3 Africa Injectable Forms Market Size
9.1.4 Africa Alendronate Market Size by Dosage Strength 2022 - 2034
9.1.4.1 Africa 5 mg Market Size
9.1.4.2 Africa 10 mg Market Size
9.1.4.3 Africa 35 mg Market Size
9.1.4.4 Africa 70 mg Market Size
9.1.5 Africa Alendronate Market Size by Application 2022 - 2034
9.1.5.1 Africa Postmenopausal Osteoporosis Market Size
9.1.5.2 Africa Osteoporosis in Men Market Size
9.1.5.3 Africa Paget’s Disease of Bone Market Size
9.1.5.4 Africa Others Market Size
9.1.6 Africa Alendronate Market Size by Route of Administration 2022 - 2034
9.1.6.1 Africa Oral Market Size
9.1.6.2 Africa Injectable Market Size
9.1.7 Africa Alendronate Market Size by Distribution Channel 2022 - 2034
9.1.7.1 Africa Hospital Pharmacies Market Size
9.1.7.2 Africa Retail Pharmacies Market Size
9.1.7.3 Africa Online Pharmacies Market Size
Chapter 10 Competitor Analysis (Subject to Data Availability (Private Players))
10.1 Top Competitors Analysis
10.1.1 Global Alendronate Market Revenue and Share by Key Players
10.1.2 Top Players Ranking 2024
10.1.3 New Product Launch Analysis
10.1.4 Industry Mergers and Acquisition Analysis
10.2 Company Profile (Data Subject to Availability) Sample Format
10.2.1 Merck & Co.
10.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.1.2 Business Overview
10.2.1.3 Financials (Subject to data availability)
10.2.1.4 R&D Investment (Subject to data availability)
10.2.1.5 Product Types Specification
10.2.1.6 Business Strategy
10.2.1.7 Recent Developments
10.2.1.8 Management Change
10.2.1.9 S.W.O.T Analysis
10.2.2 Teva Pharmaceutical Industries
10.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.2.2 Business Overview
10.2.2.3 Financials (Subject to data availability)
10.2.2.4 R&D Investment (Subject to data availability)
10.2.2.5 Product Types Specification
10.2.2.6 Business Strategy
10.2.2.7 Recent Developments
10.2.2.8 Management Change
10.2.2.9 S.W.O.T Analysis
10.2.3 Mylan N.V.
10.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.3.2 Business Overview
10.2.3.3 Financials (Subject to data availability)
10.2.3.4 R&D Investment (Subject to data availability)
10.2.3.5 Product Types Specification
10.2.3.6 Business Strategy
10.2.3.7 Recent Developments
10.2.3.8 Management Change
10.2.3.9 S.W.O.T Analysis
10.2.4 Apotex Inc.
10.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.4.2 Business Overview
10.2.4.3 Financials (Subject to data availability)
10.2.4.4 R&D Investment (Subject to data availability)
10.2.4.5 Product Types Specification
10.2.4.6 Business Strategy
10.2.4.7 Recent Developments
10.2.4.8 Management Change
10.2.4.9 S.W.O.T Analysis
10.2.5 Pfizer Inc.
10.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.5.2 Business Overview
10.2.5.3 Financials (Subject to data availability)
10.2.5.4 R&D Investment (Subject to data availability)
10.2.5.5 Product Types Specification
10.2.5.6 Business Strategy
10.2.5.7 Recent Developments
10.2.5.8 Management Change
10.2.5.9 S.W.O.T Analysis
10.2.6 Novartis AG
10.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.6.2 Business Overview
10.2.6.3 Financials (Subject to data availability)
10.2.6.4 R&D Investment (Subject to data availability)
10.2.6.5 Product Types Specification
10.2.6.6 Business Strategy
10.2.6.7 Recent Developments
10.2.6.8 Management Change
10.2.6.9 S.W.O.T Analysis
10.2.7 Eli Lilly and Company
10.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.7.2 Business Overview
10.2.7.3 Financials (Subject to data availability)
10.2.7.4 R&D Investment (Subject to data availability)
10.2.7.5 Product Types Specification
10.2.7.6 Business Strategy
10.2.7.7 Recent Developments
10.2.7.8 Management Change
10.2.7.9 S.W.O.T Analysis
10.2.8 Others
10.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.8.2 Business Overview
10.2.8.3 Financials (Subject to data availability)
10.2.8.4 R&D Investment (Subject to data availability)
10.2.8.5 Product Types Specification
10.2.8.6 Business Strategy
10.2.8.7 Recent Developments
10.2.8.8 Management Change
10.2.8.9 S.W.O.T Analysis
Chapter 11 Qualitative Analysis (Subject to Data Availability)
11.1 Market Drivers
11.2 Market Restraints
11.3 Market Trends
11.4 Market Opportunity
11.5 Technological Road Map (Subject to Data Availability)
11.6 Product Life Cycle (Subject to Data Availability)
11.7 Consumer Preference Analysis
11.8 Market Attractiveness Analysis
11.9 PESTEL Analysis
11.9.1 Political Factors
11.9.2 Economic Factors
11.9.3 Social Factors
11.9.4 Technological Factors
11.9.5 Legal Factors
11.9.6 Environmental Factors
11.10 Industrial Chain Analysis (Subject to Data Availability)
11.10.1 Industry Chain Analysis
11.10.2 Manufacturing Cost Analysis
11.10.3 Supply Side Analysis
11.10.3.1 Raw Material Analysis
11.10.3.2 Raw Material Procurement Analysis
11.10.3.3 Raw Material Price Trend Analysis
11.11 Porter’s Five Forces Analysis
11.11.1 Bargaining Power of Suppliers
11.11.2 Bargaining Power of Buyers
11.11.3 Threat of New Entrants
11.11.4 Threat of Substitutes
11.11.5 Degree of Competition
11.12 Patent Analysis (Subject to Data Availability)
11.13 ESG Analysis
Chapter 12 Market Split by Product Type Analysis 2022 - 2034
12.1 Tablets
12.1.1 Global Alendronate Revenue Market Size and Share by Tablets 2022 - 2034
12.2 Oral Solutions
12.2.1 Global Alendronate Revenue Market Size and Share by Oral Solutions 2022 - 2034
12.3 Injectable Forms
12.3.1 Global Alendronate Revenue Market Size and Share by Injectable Forms 2022 - 2034
Chapter 13 Market Split by Dosage Strength Analysis 2022 - 2034
13.1 5 mg
13.1.1 Global Alendronate Revenue Market Size and Share by 5 mg 2022 - 2034
13.2 10 mg
13.2.1 Global Alendronate Revenue Market Size and Share by 10 mg 2022 - 2034
13.3 35 mg
13.3.1 Global Alendronate Revenue Market Size and Share by 35 mg 2022 - 2034
13.4 70 mg
13.4.1 Global Alendronate Revenue Market Size and Share by 70 mg 2022 - 2034
Chapter 14 Market Split by Application Analysis 2022 - 2034
14.1 Postmenopausal Osteoporosis
14.1.1 Global Alendronate Revenue Market Size and Share by Postmenopausal Osteoporosis 2022 - 2034
14.2 Osteoporosis in Men
14.2.1 Global Alendronate Revenue Market Size and Share by Osteoporosis in Men 2022 - 2034
14.3 Paget’s Disease of Bone
14.3.1 Global Alendronate Revenue Market Size and Share by Paget’s Disease of Bone 2022 - 2034
14.4 Others
14.4.1 Global Alendronate Revenue Market Size and Share by Others 2022 - 2034
Chapter 15 Market Split by Route of Administration Analysis 2022 - 2034
15.1 Oral
15.1.1 Global Alendronate Revenue Market Size and Share by Oral 2022 - 2034
15.2 Injectable
15.2.1 Global Alendronate Revenue Market Size and Share by Injectable 2022 - 2034
Chapter 16 Market Split by Distribution Channel Analysis 2022 - 2034
16.1 Hospital Pharmacies
16.1.1 Global Alendronate Revenue Market Size and Share by Hospital Pharmacies 2022 - 2034
16.2 Retail Pharmacies
16.2.1 Global Alendronate Revenue Market Size and Share by Retail Pharmacies 2022 - 2034
16.3 Online Pharmacies
16.3.1 Global Alendronate Revenue Market Size and Share by Online Pharmacies 2022 - 2034
Chapter 17 Research Findings
17.1 Key Takeaways
17.2 Analyst Point of View
17.3 Assumptions and Acronyms
Chapter 18 Research Methodology and Sources
18.1 Primary Data Collection
18.1.1 Steps for Primary Data Collection
18.1.1.1 Identification of KOL
18.1.2 Backward Integration
18.1.3 Forward Integration
18.1.4 How Primary Research Help Us
18.1.5 Modes of Primary Research
18.2 Secondary Research
18.2.1 How Secondary Research Help Us
18.2.2 Sources of Secondary Research
18.3 Data Validation
18.3.1 Data Triangulation
18.3.2 Top Down & Bottom Up Approach
18.3.3 Cross check KOL Responses with Secondary Data
18.4 Data Representation

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us